1-3 of 3
Andras Schaffer
Close
Sort by
Journal Articles

First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

Clinical Trials & Observations
Rizwan Romee, Sarah Cooley, Melissa M. Berrien-Elliott, Peter Westervelt, Michael R. Verneris, John E. Wagner, Daniel J. Weisdorf, Bruce R. Blazar, Celalettin Ustun, Todd E. DeFor, Sithara Vivek, Lindsey Peck, John F. DiPersio, Amanda F. Cashen, Rachel Kyllo, Amy Musiek, András Schaffer, Milan J. Anadkat, Ilana Rosman, Daniel Miller, Jack O. Egan, Emily K. Jeng, Amy Rock, Hing C. Wong, Todd A. Fehniger, Jeffrey S. Miller
Journal: Blood
Blood (2018) 131 (23): 2515–2527.
https://doi.org/10.1182/blood-2017-12-823757
Published: 2018
Includes: Supplemental data
Journal Articles

Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS

Qian Zhang, HongYi Wang, Kanchan Kantekure, Jennifer C. Paterson, Xiaobin Liu, Andras Schaffer, Chrystal Paulos, Michael C. Milone, Niels Odum, Suzanne Turner, Teresa Marafioti, Mariusz A. Wasik
Journal: Blood
Blood (2011) 118 (11): 3062–3071.
https://doi.org/10.1182/blood-2011-01-332916
Published: 2011
Includes: Supplemental data
Journal Articles

Identification of Flt3 + CD150 − myeloid progenitors in adult mouse bone marrow that harbor T lymphoid developmental potential

Anthony W. S. Chi, Alejandro Chavez, Lanwei Xu, Brittany N. Weber, Olga Shestova, Andras Schaffer, Gerald Wertheim, Warren S. Pear, David Izon, Avinash Bhandoola
Journal: Blood
Blood (2011) 118 (10): 2723–2732.
https://doi.org/10.1182/blood-2010-09-309989
Published: 2011
Includes: Supplemental data